Bordetella pertussis isolates in Finland: Serotype and fimbrial expression

BMC Microbiology

Volumn 8, Issue , 2008, Pages

  Heikkinen, Eriikka ^a   Xing, Dorothy K ^b   Ölander, Rose Marie ^a   Hytönen, Jukka ^c   Viljanen, Matti K ^c   Mertsola, Jussi ^d   He, Qiushui ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c UNIVERSITY OF TURKU   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; BACTERIUM ANTIBODY; FIMBRIA PROTEIN; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FIMBRIA; FINLAND; HUMAN; INFANT; NONHUMAN; PERTUSSIS; SEROTYPE; STRAIN IDENTIFICATION; VACCINATION; BLOOD; CLASSIFICATION; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; SEROTYPING;

BORDETELLA PERTUSSIS;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; FEMALE; FIMBRIAE PROTEINS; FINLAND; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; SEROTYPING; WHOOPING COUGH;

EID: 53549121681     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-8-162     Document Type: Article

References (32)

1. The virulence factors of Bordetella pertussis: a matter of control. AM Smith CA Guzman MJ Walker, FEMS Microbiol Rev 2001 25 3 309 333 10.1111/j.1574-6976.2001.tb00580.x 11348687
2. Role of Bordetella bronchiseptica Fimbriae in Tracheal Colonization and Development of a Humoral Immune Response. S Mattoo JF Miller PA Cotter, Infect Immun 2000 68 4 2024 2033 10722598 10.1128/IAI.68.4.2024-2033.2000
3. Bordetella pertussis attachment to respiratory epithelial cells can be impaired by fimbriae-specific antibodies. ME Rodríguez SM Hellwig ML Pérez Vidakovics GA Berbers JG van de Winkel, FEMS Immunol Med Microbiol 2006 46 1 39 47 10.1111/j.1574-695X.2005.00001.x 16420595
4. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. P Olin F Rasmussen L Gustafsson HO Hallander H Heijbel, Lancet 1997 350 9091 1569 1577 10.1016/S0140-6736(97)06508-2 9393335
5. Phase and antigenic variation in bacteria. MW van der Woude AJ Baumler, Clin Microbiol Rev 2004 17 3 581 611 15258095 10.1128/CMR.17.3.581-611.2004
6. Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation. R Willems A Paul HG van der Heide AR ter Avest F Mooi, EMBO J 1990 9 9 2803 2809 1975238
7. Serological study of Bordetella pertussis and related species. G Eldering C Hornbeck J Baker, J Bacteriol 1957 74 2 133 136 13475208
8. Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains. E Heikkinen T Kallonen L Saarinen R Sara A King F Mooi J Soini J Mertsola Q He, PLoS ONE 2007 2 9 e904 17878939 10.1371/journal.pone. 0000904
9. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. SCM van Amersfoorth LM Schouls HGJ van der Heide A Advani HO Hallander K Bondeson CHW von König M Riffelmann C Vahrenholz N Guiso V Caro E Njamkepo Q He J Mertsola FR Mooi, J Clin Microbiol 2005 43 6 2837 2843 15956406 10.1128/JCM.43.6.2837-2843.2005
10. Serotype specificity of vaccine-induced immunity to pertussis. NW Preston EJ Carter, Commun Dis Rep CDR Rev 1992 2 R155 R156 1285135
11. Shifts of Bordetella pertussis variants in Sweden from 1970 to during three periods marked by different vaccination programs. HO Hallander A Advani D Donnelly L Gustafsson R-M Carlsson, J Clin Microbiol 2003 43 6 2856 2865 10.1128/JCM.43.6.2856-2865.2005
12. Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains. O Borisova SY Kombarova NS Zakharova M van Gent VA Aleshkin I Mazurova FR Mooi, Clin Vaccine Immunol 2007 14 3 234 238 17202309 10.1128/CVI.00294-06
13. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. IHM van Loo FR Mooi, Microbiology 2002 148 7 2011 2018 12101289
14. Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants? Q He J Mäkinen G Berbers FR Mooi MK Viljanen H Arvilommi J Mertsola, J Infect Dis 2003 187 8 1200 1205 10.1086/368412 12695998
15. Bordetella pertussis, Finland and France. V Caro A Elomaa D Brun J Mertsola Q He N Guiso, Emerg Infect Dis 2006 12 6 987 989 16707058
16. Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. ZM Li MJ Brennan JL David PH Carter JL Cowell CR Manclark, Infect Immun 1988 56 12 3184 3188 2903125
17. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. Q He M Viljanen H Arvilommi B Aittanen J Mertsola, JAMA 1998 280 7 635 637 10.1001/jama.280.7.635 9718056
18. Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. JL Cowell JM Zhang A Urisu A Suzuki AC Steven T Liu TY Liu CR Manclark, Infect Immun 1987 55 4 916 922 2881893
19. Characterization of fimbrial subunits from Bordetella species. FR Mooi HG van der Heide AR ter Avest KG Welinder I Livey BA van der Zeijst W Gaastra, Microb Pathog 1987 2 6 473 484 10.1016/0882-4010(87)90054-4 2907088
20. Helical structure of Bordetella pertussis fimbriae. AC Steven ME Bisher BL Trus D Thomas JM Zhang JL Cowell, J Bacteriol 1986 167 3 968 974 2875062
21. Serospecific protection of mice against intranasal infection with Bordetella pertussis. A Robinson AR Corrings SG Funnell M Fernandez, Vaccine 1989 7 4 321 324 10.1016/0264-410X(89)90193-X 2573215
22. Experimental pertussis infection in the rabbit: Similarities with infection in primates. NW Preston RM Timewell EJ Carter, J Infect 1980 2 3 227 235 10.1016/S0163-4453(80)90650-7 6309966
23. Multiple mechanisms of phase variation of PorA in Neisseria meningitidis. A van der Ende CTP Hopman J Dankert, Infect Immun 2000 68 12 6685 6690 11083782 10.1128/IAI.68.12.6685-6690.2000
24. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. J Parkhill M Sebaihia A Preston LD Murphy N Thomson DE Harris MTG Holden CM Churcher SD Bentley KL Mungall AM Cerdeno-Tarraga L Temple K James B Harris MA Quail M Achtman R Atkin S Baker D Basham N Bason I Cherevach T Chillingworth M Collins A Cronin P Davis J Doggett T Feltwell A Goble N Hamlin H Hauser S Holroyd K Jagels S Leather S Moule H Norberczak S O'Neil D Ormond C Price E Rabbinowifsch S Rutter M Sanders D Saunders K Seeger S Sharp M Simmonds J Skelton R Squares S Squares K Stevens L Unwin S Whitehead BG Barrell DJ Maskell, Nat Genet 2003 35 1 32 40 10.1038/ng1227 12910271
25. Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis. D Hot R Antoine G Renauld-Mongenie V Caro B Hennuy E Levillain L Huot G Wittmann D Poncet F Jacob-Dubuisson C Guyard F Rimlinger L Aujame E Godfroid N Guiso MJ Quentin-Millet Y Lemoine Cl Locht, Mol Genet Genomics 2003 269 4 475 486 10.1007/s00438-003-0851-1 12768411
26. Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. CA Cummings HJ Bootsma DA Relman JF Miller, J Bacteriol 2006 188 5 1775 1785 16484188 10.1128/JB.188.5.1775-1785.2006
27. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. Q He M Viljanen S Nikkari R Lyytikainen J Mertsola, J Infect Dis 1994 170 4 873 877 7930729
28. Cell-mediated immune responses to antigens of Bordetella pertussis and protection against pertussis in school children. NNT Minh Q He K Edelman R-M Ölander MK Viljanen H Arvilommi J Mertsola, Pediatr Infect Dis J 1999 18 4 366 370 10.1097/00006454-199904000-00012 10223692
29. Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA). M Viljanen O Ruuskanen C Granberg T Salmi, Scand J Infect Dis 1982 14 2 117 122 6285449
30. Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents. NN Tran Minh Q He A Ramalho A Kaufhold MK Viljanen H Arvilommi J Mertsola, Pediatrics 1999 104 6 e70 10.1542/peds.104.6.e70 10586004
31. Strain Variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years. A Elomaa A Advani D Donnelly M Antila J Mertsola H Hallander Q He, J Clin Microbiol 2005 43 8 3681 3687 16081896 10.1128/JCM.43.8.3681-3687.2005
32. Use of monoclonal antibodies to serotype Bordetella pertussis isolates: comparison of results obtained by indirect whole-cell enzyme-linked immunosorbent assay and bacterial microagglutination methods. RSW Tsang ML Sill A Advani D Xing P Newland H Hallander, J Clin Microbiol 2005 43 5 2449 2451 15872280 10.1128/JCM.43.5.2449-2451.2005